Inhibition	O
by	O
retinoic	O
acid	O
of	O
type	O
IV	O
collagenolysis	O
and	O
invasion	O
through	O
reconstituted	O
basement	B-Cellular_component
membrane	I-Cellular_component
by	O
metastatic	O
rat	O
mammary	B-Cell
adenocarcinoma	I-Cell
cells	I-Cell
.	O

The	O
activity	O
of	O
type	O
IV	O
collagenase	O
,	O
which	O
enables	O
tumor	B-Cell
cells	I-Cell
to	O
degrade	O
collagen	O
type	O
IV	O
found	O
in	O
the	O
subendothelial	B-Cellular_component
basement	I-Cellular_component
membrane	I-Cellular_component
,	O
has	O
been	O
correlated	O
with	O
the	O
metastatic	O
potential	O
in	O
several	O
tumor	B-Cancer
types	O
,	O
including	O
the	O
rat	O
13762NF	B-Cell
mammary	I-Cell
adenocarcinoma	I-Cell
cell	I-Cell
line	I-Cell
and	O
its	O
clones	B-Cell
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
whether	O
all	O
-	O
trans	O
-	O
retinoic	O
acid	O
(	O
all	O
-	O
trans	O
-	O
RA	O
)	O
and	O
other	O
retinoids	O
,	O
which	O
exhibit	O
antitumor	B-Cancer
activity	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
affect	O
the	O
collagenolytic	O
activity	O
of	O
metastatic	O
rat	O
13762NF	B-Cell
mammary	I-Cell
adenocarcinoma	I-Cell
cells	I-Cell
.	O

Cells	B-Cell
of	O
the	O
highly	O
metastatic	O
lung	B-Organ
-	O
colonizing	O
clone	B-Cell
MTF7	I-Cell
.	I-Cell
T35	I-Cell
.	I-Cell
3	I-Cell
,	O
derived	O
from	O
the	O
13762NF	B-Cell
cell	I-Cell
line	I-Cell
,	O
were	O
treated	O
for	O
3	O
days	O
with	O
0	O
.	O
1	O
,	O
1	O
,	O
or	O
10	O
microM	O
all	O
-	O
trans	O
-	O
RA	O
,	O
harvested	O
,	O
and	O
seeded	O
on	O
[	O
3H	O
]	O
proline	O
-	O
labeled	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
deposited	O
by	O
cultured	O
rat	O
lung	B-Cell
endothelial	I-Cell
cells	I-Cell
or	O
on	O
a	O
film	O
of	O
purified	O
[	O
3H	O
]	O
proline	O
-	O
labeled	O
type	O
IV	O
collagen	O
.	O

The	O
amount	O
of	O
radioactivity	O
released	O
into	O
the	O
medium	O
during	O
the	O
subsequent	O
24	O
to	O
72	O
h	O
was	O
measured	O
,	O
and	O
it	O
was	O
found	O
that	O
all	O
-	O
trans	O
-	O
RA	O
treatment	O
inhibited	O
degradation	O
of	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
and	O
type	O
IV	O
collagen	O
by	O
50	O
to	O
60	O
%	O
.	O

This	O
effect	O
was	O
observed	O
whether	O
the	O
cells	B-Cell
had	O
been	O
treated	O
with	O
all	O
-	O
trans	O
-	O
RA	O
in	O
serum	B-Organism_substance
-	O
free	O
medium	O
or	O
in	O
medium	O
supplemented	O
with	O
heat	O
-	O
inactivated	O
or	O
acid	O
-	O
treated	O
fetal	B-Organism_substance
bovine	I-Organism_substance
serum	I-Organism_substance
.	O

The	O
growth	O
of	O
the	O
cells	B-Cell
was	O
not	O
inhibited	O
under	O
these	O
conditions	O
,	O
except	O
after	O
treatment	O
with	O
10	O
microM	O
all	O
-	O
trans	O
-	O
RA	O
in	O
serum	B-Organism_substance
-	O
free	O
medium	O
.	O

The	O
reduction	O
in	O
collagenolytic	O
activity	O
was	O
observed	O
in	O
viable	O
cells	B-Cell
as	O
well	O
as	O
in	O
conditioned	O
medium	O
.	O

A	O
24	O
-	O
h	O
exposure	O
of	O
cells	B-Cell
to	O
all	O
-	O
trans	O
-	O
RA	O
was	O
sufficient	O
to	O
cause	O
a	O
30	O
%	O
decrease	O
in	O
the	O
collagenolytic	O
activity	O
,	O
and	O
this	O
inhibitory	O
effect	O
was	O
reversible	O
.	O

The	O
direct	O
addition	O
of	O
all	O
-	O
trans	O
-	O
RA	O
to	O
conditioned	O
medium	O
had	O
no	O
effect	O
on	O
secreted	O
collagenase	O
activity	O
.	O

The	O
apparent	O
molecular	O
weights	O
of	O
the	O
collagenolytic	O
enzymes	O
were	O
determined	O
by	O
electrophoresis	O
of	O
cell	B-Organism_substance
extracts	I-Organism_substance
and	O
concentrated	O
conditioned	O
medium	O
in	O
type	O
IV	O
collagen	O
-	O
embedded	O
polyacrylamide	O
gels	O
followed	O
by	O
renaturation	O
and	O
activation	O
of	O
the	O
enzymes	O
within	O
the	O
gels	O
.	O

Two	O
major	O
type	O
IV	O
collagenolytic	O
metalloproteinases	O
exhibiting	O
molecular	O
weights	O
of	O
64	O
,	O
000	O
and	O
88	O
,	O
000	O
,	O
respectively	O
,	O
were	O
detected	O
by	O
this	O
method	O
.	O

These	O
two	O
enzymes	O
were	O
also	O
found	O
to	O
have	O
specificity	O
for	O
gelatin	O
.	O

The	O
Mr	O
64	O
,	O
000	O
enzyme	O
could	O
be	O
extracted	O
from	O
viable	O
cells	B-Cell
(	O
presumably	O
from	O
the	O
cell	B-Cellular_component
membrane	I-Cellular_component
)	O
by	O
2	O
%	O
1	O
-	O
butanol	O
.	O

Treatment	O
with	O
all	O
-	O
trans	O
-	O
RA	O
decreased	O
the	O
level	O
of	O
these	O
enzymes	O
in	O
the	O
cellular	B-Cell
,	O
cell	B-Cellular_component
membrane	I-Cellular_component
,	O
and	O
conditioned	O
medium	O
compartments	O
.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

